Tallon, D., Wiles, N., Campbell, J., Chew-Graham, C., Dickens, C., Macleod, U., Peters, T. J., Lewis, G., Anderson, I. M., Gilbody, S., Hollingworth, W., Davies, S., & Kessler, D. (2016). Mirtazapine added to selective serotonin reuptake inhibitors for treatment-resistant depression in primary care (MIR trial): Study protocol for a randomised controlled trial. Trials, 17(1), Article 66. https://doi.org/10.1186/s13063-016-1199-2